crystalline form of a hydrate, process for preparing the crystalline form, pharmaceutical composition, crystalline form, pharmaceutical combination, crystalline hydrate and crystals

摘要

Summary The present invention relates to 1- (α-d-glycopyranyl) -4-methyl-3- [5- (4-fluorophenyl) -2-thienylmethyl] benzene non-stoichiometric crystalline hydrates, processes for their preparation and their use as medicines. furthermore, the present invention relates to pharmaceutical compositions comprising an effective amount of the novel crystalline hydrates.